VNQI, SHG, GNMK, VTWV, VTWG, SCHF Are Seasonally Ripe To Go Down In the Next Five Weeks
January 4, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Vngd Glb ex-US RE (NASDAQ:VNQI), Shinhan Financial Group (NYSE:SHG), GenMark Diagnostics Inc. (NASDAQ:GNMK), Vanguard Russell 2000 Value ETF (NASDAQ:VTWV), Vanguard Russell 2000 Growth ETF (NASDAQ:VTWG), Schwab International Equity ETF (NYSE:SCHF) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date VNQI Vngd Glb ex-US RE -0.84% 66.67% (4 of 6) Thursday, January 5th 2017 SHG Shinhan Financial Group -2.02% 84.62% (11 of 13) Friday, January 6th 2017 GNMK GenMark Diagnostics Inc. -2.05% 100.00% (6 of 6) Thursday, January 5th 2017 VTWV Vanguard Russell 2000 Value ETF -0.80% 66.67% (4 of 6) Thursday, January 5th 2017 VTWG Vanguard Russell 2000 Growth ETF -0.74% 100.00% (6 of 6) Thursday, January 5th 2017 SCHF Schwab International Equity ETF -0.89% 85.71% (6 of 7) Thursday, January 5th 2017Vngd Glb ex-US RE (NASDAQ:VNQI) - .
Shinhan Financial Group (NYSE:SHG) - Shinhan Financial Group Co., Ltd. provides various financial products and services in South Korea and internationally. The company s retail banking services include mortgage and home equity, and retail lending products; demand, savings, and fixed deposit-taking; checking accounts, and electronic banking and automatic teller machine (ATM) services; and bill paying, payroll and check-cashing, currency exchange, and wire fund transfer services. It also provides corporate banking services, such as investment banking, real estate financing, overseas real estate project financing, development project financing, infrastructure financing, structured financing, equity investments/venture investments, mergers and acquisitions consulting, and securitization; derivative services consisting of securities and derivative products, and foreign exchange trading; working capital loans and facilities loans; and treasury services. In addition, the company engages in treasury and investment activities in international capital markets, including foreign currency-denominated securities trading, foreign exchange trading and services, trade-related financial services, international factoring services, and foreign banking operations. Further, it provides trust account management, credit card, securities brokerage, life insurance, and asset management services, as well as leasing and equipment financing, regional and savings banking, loan collection and credit reporting, collective investment administration, private equity investment, and financial system development services. As of December 31, 2015, the company operated a network of 900 service centers, 6,816 ATMs, 3 cash dispensers, and 24 digital kiosks. Shinhan Financial Group Co., Ltd. was founded in 1982 and is headquartered in Seoul, South Korea..
GenMark Diagnostics Inc. (NASDAQ:GNMK) - GenMark Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, commercializes, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology. Its products include XT-8 system that enables reference laboratories and hospitals to perform a range of molecular diagnostic and research tests with a workstation and disposable test cartridge. The company offers eight diagnostic tests for use with its XT-8 system that includes Respiratory Viral Panel, Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test, Thrombophilia Risk Test, hepatitis C virus, genotyping tests, and custom manufactured reagents, as well as provides versions for other research-based and pharmacogenomics products. It also provides ePlex system, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using the ePlex system to place the patient sample into the test cartridge and obtain results without any additional steps. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California..
Vanguard Russell 2000 Value ETF (NASDAQ:VTWV) - The investment seeks to track the performance of a benchmark index that measures the investment return of small-capitalization value stocks in the United States. The fund employs an indexing investment approach designed to track the performance of the Russell 2000 Value Index. The index is designed to measure the performance of small-capitalization value stocks in the United States. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index..
Vanguard Russell 2000 Growth ETF (NASDAQ:VTWG) - The investment seeks to track the performance of a benchmark index that measures the investment return of small-capitalization growth stocks in the United States. The fund employs an indexing investment approach designed to track the performance of the Russell 2000 Growth Index. The index is designed to measure the performance of small-capitalization growth stocks in the United States. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index..
Schwab International Equity ETF (NYSE:SCHF) - The Charles Schwab Corporation.
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net